Heparin modulates integrin-mediated cellular adhesion:: Specificity of interactions with α and β integrin subunits

Heparin is known to influence the growth, proliferation, and migration of vascular cells, but the precise mechanisms are unknown. We previously demonstrated that unfractionated heparin (UH) binds to the platelet integrin alpha(IIb)beta(3) , and enhances ligand binding. To help define the specificity and site(s) of heparin-integrin interactions, we employed the erythroleukemic K562 cell line, transfected to express specific integrins (alpha(v)beta(3) , alpha(v)beta(5) , and alpha(IIb)beta(3)). By comparing K562 cells expressing a common alpha subunit (Kalpha (v)beta(3) , Kalpha(v)beta(5)) with cells expressing a common beta subunit (Kalpha (v)beta(3) , Kalpha(IIb)beta(3)), we observed that heparin differentially modulated integrin-mediated adhesion to vitronectin. UH at 0.5-7.5 mug/ml consistently enhanced the adhesion of beta(3) expressing cells (Kalpha(v)beta(3) ,Kalpha(IIb)beta(3)). In contrast, UH at 0.5-7.5 mug/ml inhibited Kalpha(v)beta(5) adhesion. Experiments using integrin-blocking antibodies, appropriate control ligands, and nontransfected native K562 cells revealed that heparin's actions were mediated by the specific integrins under study. Preincubation of heparin with Kalpha(v)beta(3) cells enhanced adhesion, while preincubation of heparin with the adhesive substrate (vitronectin) had minimal effect. There was a structural specificity to heparin's effect, in that a low molecular weight heparin and chondroitin sulfate showed significantly less enhancement of adhesion. These findings suggest that heparin's modulation of integrin-ligand interactions occurs through its action on the integrin. The inhibitory or stimulatory effects of heparin depend on the beta subunit type, and the potency is dictated by structural characteristics of the glycosaminoglycan.